IN-DATE
CSK-6131-SD: AtriCure Subtle Cannula w/Guide Kit, 30cm (No Box)
Sign in to add this product to your favorites!
| Price: | $89.99 EACH |
|---|---|
| Quantity: | |
| In Stock: | 4 eaches |
| Expiration: | 09-2026 |
| Express: | Need it tomorrow? Order in next 6 hours 19 minutes and choose overnight shipping at checkout. |
Additional Details
AtriCure Subtle Cannula
The Subtle Cannula allows the surgeon to access the atria through a one inch incision in the abdomen. Through the Cannula, an endoscope and the coagulation device are introduced into the pericardial space enabling access to the posterior surface of the heart for coagulating epicardial cardiac tissue.
The Cannula with guidewire is indicated for use in laparoscopic or general surgery to provide access for operative and diagnostic instrumentation in body cavity spaces.
AccessGUDID Info
- FDA Product Code: OCM
- FDA Product Code Name: Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation
- GMDN Term Code: 60784
- GMDN Term Name: Cardiac radio-frequency ablation system generator
- GMDN Term Description: An electrically-powered, noninvasive device intended to be used to generate radio-frequency energy to create ablative lesions in the cardiac tissue of a beating heart in the treatment of cardiac arrhythmias. The generator includes controls and may include electrocardiograph (ECG) interfacing/monitoring functionality. It may be intended to be used with a radio-frequency catheter for endocardial ablation and/or an epicardial probe for epicardial ablation.
Manufacturer
AtriCure is a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions. Electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. The Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. The AtriClip Left Atrial Appendage Exclusion System products are the most widely used LAA management devices worldwide. The Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients, and the cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures.
